Stockreport

Entero Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds [Yahoo! Finance]

Entero Therapeutics Inc.  (ENTO) 
PDF biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced it has entered into agr [Read more]